Skip to main content
. 2023 Jan 28;12(2):297. doi: 10.3390/antiox12020297

Figure 1.

Figure 1

Obesity-associated disruption of hypothalamic functionality. AGEs, advanced glycation end-products; CCL-2 chemokine (C-C motif) ligand 2; LPS, lipopolysaccharide; SFCAs, short chain fatty acids; sFFAs, saturated fatty free acids; TNFα, tumor necrosis factor-α.